Showing results (2161-2170 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 16, 2019
The cellular effects of novel triazine nitrogen mustards in glioblastoma LBC3, LN-18 and LN-229 cell linesRafał Krętowski, Danuta Drozdowska, Beata Kolesińska, et al.Investigational New Drugs|December 25, 2019
Discovery of a novel and highly selective CDK9 kinase inhibitor (JSH-009) with potent antitumor efficacy in preclinical acute myeloid leukemia modelsLi Wang, Chen Hu, Aoli Wang, et al.Investigational New Drugs|December 14, 2019
Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cellsJie Hu, Enxin Wang, Lei Liu, et al.Investigational New Drugs|December 16, 2019
Design, synthesis and cytotoxicity of the antitumor agent 1-azabicycles for chemoresistant glioblastoma cellsMona Oliveira, Lourenço Luis Botelho de Santana, José Claudio Serafim, et al.Investigational New Drugs|February 22, 2018
Pazopanib-related tumor lysis syndrome in metastatic clear cell renal cell carcinoma: a case reportMichael W van Kalleveen, Maudy Walraven, Mathijs P HendriksInvestigational New Drugs|July 2, 2016
Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumorsHidenori Mizugaki, Noboru Yamamoto, Haruyasu Murakami, et al.Investigational New Drugs|June 24, 2016
Involvement of AMP-activated protein kinase in mediating pyrrolo-1,5-benzoxazepine-induced apoptosis in neuroblastoma cellsJennifer C Lennon, Stefania Butini, Giuseppe Campiani, et al.Investigational New Drugs|January 1, 1987
Drug sensitivity of ten human tumor cell lines compared to mouse leukemia (L1210) cellsG J Badiner, R D Hamilton, L H Li, et al.Investigational New Drugs|January 1, 1987
Release of methyl isocyanate from the antitumor agent caracemide (NSC-253272)R A Newman, D FarquharInvestigational New Drugs|January 24, 2023
Viscosalactone B, a natural LSD1 inhibitor, inhibits proliferation in vitro and in vivo against prostate cancer cellsGaobo Yan, Hongyan Zhang, Yan Li, et al.Pageof 372